Al-Razi Medical Company (TADAWUL:9572)

Al-Razi Medical Company Income Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	64.13	61.35	61.33	52.39	45.19
Revenue Growth (YoY)	3.45%	0.03%	17.07%	15.95%	-
Cost of Revenue	46.82	44.95	44.03	36.42	32.23
Gross Profit	17.31	16.4	17.3	15.97	12.95
Selling, General & Admin	16.55	16.02	16	13.39	10.53
Other Operating Expenses	-0.66	-0.66	-0.27	-	-
Operating Expenses	15.9	15.36	15.75	13.4	10.53
Operating Income	1.41	1.04	1.55	2.57	2.42
Interest Expense	-0.71	-0.51	-0.48	-0.3	-0.37
Other Non Operating Income (Expenses)	-0.05	-	-	0.15	0.48
EBT Excluding Unusual Items	0.66	0.53	1.08	2.43	2.53
Gain (Loss) on Sale of Assets	-	-	0.01	-	-
Pretax Income	0.66	0.53	1.09	2.43	2.53
Income Tax Expense	0.37	0.35	0.4	0.41	0.37
Net Income	0.28	0.18	0.69	2.01	2.16
Net Income to Common	0.28	0.18	0.69	2.01	2.16
Net Income Growth	213.78%	-74.36%	-65.95%	-6.87%	-
Shares Outstanding (Basic)	2	2	2	2	2
Shares Outstanding (Diluted)	2	2	2	2	2
EPS (Basic)	0.19	0.12	0.45	1.33	1.42
EPS (Diluted)	0.19	0.12	0.45	1.33	1.42
EPS Growth	213.79%	-74.36%	-65.95%	-6.87%	-
Free Cash Flow	0.81	1.1	1	-0.64	-2.82
Free Cash Flow Per Share	0.53	0.72	0.66	-0.42	-1.86
Dividend Per Share	-	-	1.587	-	-
Gross Margin	26.99%	26.73%	28.21%	30.49%	28.67%
Operating Margin	2.21%	1.70%	2.54%	4.91%	5.36%
Profit Margin	0.44%	0.29%	1.12%	3.84%	4.79%
Free Cash Flow Margin	1.27%	1.79%	1.63%	-1.22%	-6.25%
EBITDA	3.13	2.68	2.98	3.64	3.32
EBITDA Margin	4.88%	4.37%	4.86%	6.94%	7.34%
D&A For EBITDA	1.72	1.64	1.43	1.06	0.9
EBIT	1.41	1.04	1.55	2.57	2.42
EBIT Margin	2.21%	1.70%	2.54%	4.91%	5.36%
Effective Tax Rate	57.03%	66.80%	36.82%	16.94%	14.61%
Advertising Expenses	-	0.1	0.27	0.09	0.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.